TLR9 and beclin 1 crosstalk regulates muscle AMPK activation in exercise.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
02 2020
Historique:
received: 07 09 2018
accepted: 12 12 2019
pubmed: 14 2 2020
medline: 4 4 2020
entrez: 14 2 2020
Statut: ppublish

Résumé

The activation of adenosine monophosphate-activated protein kinase (AMPK) in skeletal muscle coordinates systemic metabolic responses to exercise

Identifiants

pubmed: 32051584
doi: 10.1038/s41586-020-1992-7
pii: 10.1038/s41586-020-1992-7
pmc: PMC7047589
mid: NIHMS1546557
doi:

Substances chimiques

Beclin-1 0
Becn1 protein, mouse 0
Tlr9 protein, mouse 0
Toll-Like Receptor 9 0
Tumor Suppressor Proteins 0
UVRAG protein, mouse 0
Phosphatidylinositol 3-Kinase EC 2.7.1.137
AMP-Activated Protein Kinases EC 2.7.11.31
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

605-609

Subventions

Organisme : NCI NIH HHS
ID : R01 CA109618
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109725
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI142784
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Kjøbsted, R. et al. AMPK in skeletal muscle function and metabolism. FASEB J. 32, 1741–1777 (2018).
doi: 10.1096/fj.201700442R
Levine, B. & Kroemer, G. Biological functions of autophagy genes: a disease perspective. Cell 176, 11–42 (2019).
doi: 10.1016/j.cell.2018.09.048
He, C. et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481, 511–515 (2012).
doi: 10.1038/nature10758
Pandey, S., Kawai, T. & Akira, S. Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. Cold Spring Harb. Perspect. Biol. 7, a016246 (2015).
doi: 10.1101/cshperspect.a016246
Wei, Y., Pattingre, S., Sinha, S., Bassik, M. & Levine, B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 30, 678–688 (2008).
doi: 10.1016/j.molcel.2008.06.001
West, A. P. & Shadel, G. S. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat. Rev. Immunol. 17, 363–375 (2017).
doi: 10.1038/nri.2017.21
Shintani, Y. et al. TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons. Proc. Natl Acad. Sci. USA 110, 5109–5114 (2013).
doi: 10.1073/pnas.1219243110
Zhou, D. C. et al. CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis. J. Cell. Physiol. 233, 4245–4257 (2018).
doi: 10.1002/jcp.26243
Omiya, S. et al. Toll-like receptor 9 prevents cardiac rupture after myocardial infarction in mice independently of inflammation. Am. J. Physiol. Heart Circ. Physiol. 311, H1485–H1497 (2016).
doi: 10.1152/ajpheart.00481.2016
Rostislavleva, K. et al. Structure and flexibility of the endosomal Vps34 complex reveals the basis of its function on membranes. Science 350, aac7365 (2015).
doi: 10.1126/science.aac7365
Guan, Y., Drake, J. C. & Yan, Z. Exercise-induced mitophagy in skeletal muscle and heart. Exerc. Sport Sci. Rev. 47, 151–156 (2019).
doi: 10.1249/JES.0000000000000192
De Leo, M. G. et al. Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL. Nat. Cell Biol. 18, 839–850 (2016).
doi: 10.1038/ncb3386
Ewald, S. E. et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456, 658–662 (2008).
doi: 10.1038/nature07405
Majer, O. et al. Release from UNC93B1 reinforces the compartmentalized activation of select TLRs. Nature 575, 371–374 (2019).
doi: 10.1038/s41586-019-1611-7
Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000).
doi: 10.1038/35047123
Zisman, A. et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6, 924–928 (2000).
doi: 10.1038/78693
Xie, Z., Dong, Y., Scholz, R., Neumann, D. & Zou, M. H. Phosphorylation of LKB1 at serine 428 by protein kinase C-ζ is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells. Circulation 117, 952–962 (2008).
doi: 10.1161/CIRCULATIONAHA.107.744490
Cokorinos, E.C. et al. Activation of skeletal muscle AMPK promotes glucose disposal and glucose lowering in non-human primates and mice. Cell Metab. 25, 1147–1159 (2017).
doi: 10.1016/j.cmet.2017.04.010
Wei, Y. et al. The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation. eLife 4, e05289 (2015).
doi: 10.7554/eLife.05289
Hurley, J. H. & Young, L. N. Mechanisms of autophagy initiation. Annu. Rev. Biochem. 86, 225–244 (2017).
doi: 10.1146/annurev-biochem-061516-044820
Henault, J. et al. Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity 37, 986–997 (2012).
doi: 10.1016/j.immuni.2012.09.014
Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T. & Ohsumi, Y. In vivo analysis of autophagy in resporense to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell 15, 1101–1111 (2004).
doi: 10.1091/mbc.e03-09-0704
Shoji-Kawata, S. et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494, 201–206 (2013).
doi: 10.1038/nature11866
Lee, B. L. et al. UNC93B1 mediates differential trafficking of endosomal TLRs. eLife 2, e00291 (2013).
doi: 10.7554/eLife.00291
Ranaghan, M. J. et al. The autophagy-related beclin-1 protein requires the coiled-coil and BARA domains to form a homodimer with submicromolar affinity. Biochemistry 56, 6639–6651 (2017).
doi: 10.1021/acs.biochem.7b00936
Agathocleous, M. et al. Ascorbate regulates haematopoietic stem cell function and leukaemogenesis. Nature 549, 476–481 (2017).
doi: 10.1038/nature23876
Aslesen, R. & Jensen, J. Effects of epinephrine on glucose metabolism in contracting rat skeletal muscles. Am. J. Physiol. 275, E448–E456 (1998).
pubmed: 9725811
Jensen, T. E. et al. PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain. Biochem. J. 467, 461–472 (2015).
doi: 10.1042/BJ20141142
Chen, H. et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141, 280–289 (2010).
doi: 10.1016/j.cell.2010.02.026
White, M. J. et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159, 1549–1562 (2014).
doi: 10.1016/j.cell.2014.11.036
Millay, D. P. et al. Myomaker is a membrane activator of myoblast fusion and muscle formation. Nature 499, 301–305 (2013).
doi: 10.1038/nature12343
Plaideau, C. et al. Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle. Chem. Biol. 21, 1497–1510 (2014).
doi: 10.1016/j.chembiol.2014.09.013

Auteurs

Yang Liu (Y)

Center for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. yang.liu3@utsouthwestern.edu.
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA. yang.liu3@utsouthwestern.edu.

Phong T Nguyen (PT)

Center for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Xun Wang (X)

Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Yuting Zhao (Y)

Center for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Corbin E Meacham (CE)

Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Zhongju Zou (Z)

Center for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Bogdan Bordieanu (B)

Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Manuel Johanns (M)

De Duve Institute, Université Catholique de Louvain, Brussels, Belgium.

Didier Vertommen (D)

De Duve Institute, Université Catholique de Louvain, Brussels, Belgium.

Tobias Wijshake (T)

Center for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Herman May (H)

Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Guanghua Xiao (G)

Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Sanae Shoji-Kawata (S)

Center for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Mark H Rider (MH)

De Duve Institute, Université Catholique de Louvain, Brussels, Belgium.

Sean J Morrison (SJ)

Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Prashant Mishra (P)

Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Beth Levine (B)

Center for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. beth.levine@utsouthwestern.edu.
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA. beth.levine@utsouthwestern.edu.
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. beth.levine@utsouthwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH